CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 20 other locations
The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...
Phase 3
Philadelphia, Pennsylvania, United States and 85 other locations
Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM)....
Phase 2
Philadelphia, Pennsylvania, United States
This research study is for Glioblastoma (GBM) patients who will be beginning Optune as part of their clinical care, which is a nove...
Philadelphia, Pennsylvania, United States and 1 other location
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Philadelphia, Pennsylvania, United States and 60 other locations
This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...
Phase 2
Philadelphia, Pennsylvania, United States and 80 other locations
This is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid t...
Phase 1
Philadelphia, Pennsylvania, United States and 12 other locations
The purpose of this study is to evaluate patients with glioblastoma that is MGMT-methylated (the MGMT gene is altered by a chemical change)....
Phase 3
Philadelphia, Pennsylvania, United States and 122 other locations
INCMGA00012, and stereotactic radiosurgery (SRS) for recurrent Glioblastoma (GBM). The investigators hypothesize that the proposed ...
Phase 2
Philadelphia, Pennsylvania, United States
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...
Phase 2
Philadelphia, Pennsylvania, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal